····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ···...
บริษัท ทาคูนิ กรุ๊ป จ ากดั (มหาชน) เลขท่ี 140/1 ถนนกาญจนาภิเษก แขวง/เขตบางแค จังหวัดกรุงเทพฯ 10160 โทร. 02-455-2888 แฟกซ์. 02-455-2763 TAKUNI GROUP PUBLIC COMPANY LIMITED 140/1 KHANJANAPISEK RD
บริษัท ทาคูนิ กรุ๊ป จ ากดั (มหาชน) เลขท่ี 140/1 ถนนกาญจนาภิเษก แขวง/เขตบางแค จังหวัดกรุงเทพฯ 10160 โทร. 02-455-2888 แฟกซ์. 02-455-2763 TAKUNI GROUP PUBLIC COMPANY LIMITED 140/1 KHANJANAPISEK RD
Dental Public Company Limited (LDC) would like to clarify the performance of the Company for the 3 months period ended March 31, 2019 which the details are as follows: 1. Performance Analysis 1.1
บริษัท ทาคูนิ กรุ๊ป จ ากดั (มหาชน) เลขท่ี 140/1 ถนนกาญจนาภิเษก แขวง/เขตบางแค จังหวัดกรุงเทพฯ 10160 โทร. 02-455-2888 แฟกซ์. 02-455-2763 TAKUNI GROUP PUBLIC COMPANY LIMITED 140/1 KHANJANAPISEK RD
, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
426 76% EBITDA 24 81 238% 114 223 96% Net Profit (Loss) for the Company (13) 34 362% (9) 82 1,011% Gross Profit Margin (%) 52.2% 64.6% 12.5% 56.1% 63.2% 7.1% EBITDA Margin1 (%) 20.7% 32.8% 12.1% 26.2
11 Management Discussion and Analysis Fiscal year ended February 28, 2019 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) already submitted the audited financial statements for
บริษัท จี เจ สตีล จํากัด (มหาชน) G J Steel Public Company Limited GJS Management Discussion and Analysis Q2/2020 1. Operating Result Highlights Unit: million Baht 2nd Quarter 2020 2nd Quarter 2019 Pe
67% EBITDA 58 83 43% 172 306 78% Net Profit (Loss) for the Company 13 36 177% 4 118 2,850% Gross Profit Margin (%) 59.6% 62.9% 3.3% 57.3% 63.1% 5.8% EBITDA Margin1 (%) 30.1% 30.9% 0.8% 27.4% 32.1% 4.7